NCT00731874 Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status Status TERMINATED Phase PHASE4
NCT00720629 Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation Status TERMINATED Phase PHASE2
NCT00717379 Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation Status COMPLETED Phase PHASE4
NCT00709592 Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT Status COMPLETED Phase PHASE2
NCT00693524 Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX Status COMPLETED Phase PHASE2
NCT00693446 A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids Status UNKNOWN Phase PHASE4
NCT00693381 Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation Status COMPLETED Phase PHASE3
NCT00686855 Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT00670423 A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Status COMPLETED Phase PHASE1
NCT00669890 Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML Status TERMINATED Phase PHASE1
NCT00650468 A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients Status COMPLETED Phase PHASE4
NCT00643071 Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients Status COMPLETED Phase PHASE3
NCT00637143 Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF) Status COMPLETED Phase PHASE4
NCT00623012 Rapamycin for Prevention of Chronic Graft-Versus-Host Disease Status TERMINATED Phase PHASE1/PHASE2
NCT00622895 Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00617604 A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients Status COMPLETED Phase PHASE2
NCT00612274 Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Status COMPLETED Phase EARLY_PHASE1
NCT00611351 Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00609388 Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation Status COMPLETED Phase PHASE4
NCT00596947 Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant Status TERMINATED Phase PHASE4